Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
01/2005
01/06/2005WO2005001060A2 Novel calcium channel
01/06/2005WO2005001057A2 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
01/06/2005WO2005001055A2 Stabilized immunomodulatory oligonucleotides
01/06/2005WO2005001052A2 Modulation of apoptosis
01/06/2005WO2005001043A2 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF FNAi
01/06/2005WO2005001034A2 Rna-exit-channel: target and method for inhibition of bacterial rna polymerase
01/06/2005WO2005001031A2 Modulation of the rna interference pathway
01/06/2005WO2005001030A2 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
01/06/2005WO2005001025A2 Immunoglobulin chimeric monomer-dimer hybrids
01/06/2005WO2005001024A2 Genes encoding carotenoid compounds
01/06/2005WO2005000888A2 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF
01/06/2005WO2005000235A2 NUCLEIC ACID SEQUENCES ENCODING AND COMPOSITIONS COMPRISING IgE SIGNAL PEPTIDE AND/OR IL-15 AND METHODS FOR USING THE SAME
01/06/2005WO2005000234A2 Novel coronavirus inhibitors
01/06/2005WO2005000220A2 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
01/06/2005WO2005000215A2 Methods for treating pain
01/06/2005WO2005000200A2 Novel kinases
01/06/2005WO2005000198A2 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same
01/06/2005WO2005000098A2 Detection methods for disorders of the lung
01/06/2005WO2005000088A2 Expression profile of pancreatic cancer
01/06/2005WO2004054512A3 Therapeutic retroviral vectors for gene therapy
01/06/2005WO2003097688A9 Muteins of placental growth factor type 1, preparation method and application thereof
01/06/2005WO2002096923A9 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
01/06/2005US20050005314 Animal model comprising constitutively exprressed anaplastic lymphoma kinase (ALK) gene for use in identifying agents which prevent and treat tumor metastasis; gene expression inhibition; RNA interference; immunotherapy
01/06/2005US20050004356 Linker nucleoside, its preparation and use
01/06/2005US20050004350 Novel chemiluminescent reagents
01/06/2005US20050004348 Sodium transport protein for use as tool in identifying modulator for treatment of hyperphosphatemia or hypophosphatemia
01/06/2005US20050004078 Nucleotide analogs with six-membered rings
01/06/2005US20050004062 Immunostimulatory oligonucleotides; activation lymphocytes; antibody therapy; anticancer agents
01/06/2005US20050004061 Immunostimulatory nucleic acid molecules
01/06/2005US20050003487 Chordin dorsalizing and hemoglobin inducing polypeptides and nucleic acids encoding the same
01/06/2005US20050003482 Expression vector comprising nucleotide sequences coding foot and mouth viral, as well as, immunoglobulin sequences for use in generation imunotherapeutics
01/06/2005US20050003474 Carotenoid biosynthesis
01/06/2005US20050003444 Novel human polynucleotides and the polypeptides encoded thereby
01/06/2005US20050003443 Oligonucleotide sequences for use as tools in gene discovery, gene expression analysis, forensics and disease diagnosis
01/06/2005US20050003441 Methods and compositions for amplification of RNA sequences
01/06/2005US20050003436 Release of intracellular material
01/06/2005US20050003429 Apparatus which utilizes changes in redox potential to detect preferential nucleic acids; identifying variation in nucleotide sequences using hybridization analysis
01/06/2005US20050003421 Bioarray chip reaction apparatus and its manufacture
01/06/2005US20050003418 Multiplex PCR primer set for amplifying human MODY genes 1,4,5,6 and 7
01/06/2005US20050003414 Expression vector comprising artificial chromosome and and avian regulatory sequences for use as tool in heterologous gene transfer and expression
01/06/2005US20050003408 Libraries of oligomers labeled with different tags
01/06/2005US20050003406 Using expression pattern of notch signaling pathway protein (JAG2) as diagnostic indicator of cell proliferative disorders
01/06/2005US20050003405 Using g protein coupled receptors expression as diagnostic/prognostic indicator of cell proliferative disorders; immunotherapy
01/06/2005US20050003403 Multimeric protien for use in treatment and prevention of infections, nervous system, inflammatory, autoimmune and cell proliferative disorders
01/06/2005US20050003402 Nucleotide sequences coding protein transiently associated with the kinetochore complex during mitosis for use as tool in diagnosis, prevention and treatment of cell proliferative disorders
01/06/2005US20050003386 Methods and compositions for detection and analysis of polynucleotide-binding protein interactions using light harvesting multichromophores
01/06/2005US20050003371 Modified nucleotides and methods of labeling nucleic acids
01/06/2005US20050003363 Method of screening for agents inhibiting chloride intracellular channels
01/06/2005US20050003354 Generating enhanced regulatory region via random rearrangement of transcriptional activating components; immproving efficiency ofheterologous gene expression
01/06/2005US20050003344 Adeno-associated viral deletion rep protein comprising functional nuclear localization sequence for use delivery of gene products to preferential intracellular locations
01/06/2005US20050002968 Flavivirus vaccines
01/06/2005US20050002938 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers
01/06/2005CA2771875A1 Variant humicola grisea cbh1.1
01/06/2005CA2530248A1 Modified vectors for organelle transfection
01/06/2005CA2530020A1 Novel .beta.-actin and rps21 promoters and uses thereof
01/06/2005CA2529145A1 Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same
01/06/2005CA2529103A1 Use of a recombinant vector encoding il-10 for treating neuropathic pain
01/06/2005CA2528597A1 Stabilized immunomodulatory oligonucleotides
01/06/2005CA2528572A1 Gene expression analysis of airway epithelial cells for diagnosing lung cancer
01/06/2005CA2527959A1 Plant fatty acid amide hydrolases
01/06/2005CA2527958A1 Methods and compositions for enhancing the efficacy and specificity of rnai
01/06/2005CA2526639A1 Chimeric rnas and their use for cancer diagonostics and therapy
01/06/2005CA2525333A1 Trichoderma genes
01/06/2005CA2522867A1 Genes encoding carotenoid compounds
01/05/2005EP1493825A2 Method for producing nucleic acid ligands
01/05/2005EP1493818A2 Nucleoside triphosphates and their incorporation into ribozymes
01/05/2005EP1493817A1 Resistance against plant pests
01/05/2005EP1493812A2 A truncated keratinocyte growth factor (KGF) having increased biological activity
01/05/2005EP1492879A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
01/05/2005EP1492812A2 Modulator of the notch signalling pathway and use thereof in medical treatment
01/05/2005EP1492805A2 System for tracing animal products
01/05/2005EP1492804A1 Process for isolating nucleic acid with chaotrope agents and ammonium compounds
01/05/2005EP1492404A2 Novel spinosyn-producing polyketide synthases
01/05/2005EP1200580B1 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES
01/05/2005EP1018549B1 Method for isolating dna
01/05/2005EP0730609B1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders
01/05/2005CN1560252A Nucleotide to 0-antigen specificity of escherichia coli 0154 type
01/05/2005CN1560251A Nucleotide to 0-antigen specificity of Escherichia coli 0140 type
01/05/2005CN1560112A Conjugated compound of macrocyclic polyamine with polyamide and preparation process and application thereof
01/05/2005CN1560080A Corpuscles of stannius protein, stanniocalcin
01/05/2005CN1560068A Process for producing deoxyribonucleoside by thymus of pig, sheep or chicken duck as raw material
01/05/2005CN1560067A Low pH screening solution system for separating capillary electrophoresis DNA fragment
01/05/2005CN1560066A Recombined immune toxin protein of anticryptic sporozoan and its preparation process and medical application
01/05/2005CN1560053A Compound of poly-amide macrocyclic polyamine and its preparation process and application
01/04/2005US6838594 Limnanthes oil genes
01/04/2005US6838549 For treatment of leukemia; enhancing bone marrow recovery in allogeneic or autologous transplantation and in treatment, radiation, chemically, or chemotherapeutically induced aplasia or myelosuppression
01/04/2005US6838447 Immobilized nucleotide chargable particles
01/04/2005US6838283 Antitumor agents
01/04/2005US6838281 Cells expressing fusion proteins of immunoglobulins
01/04/2005US6838273 Cloning and characterization of the FLBA gene of H. pylori, production of aflagellate strains
01/04/2005US6838257 Pullulanase variants and methods for preparing such variants with predetermined properties
01/04/2005US6838244 A labeled fluorescent oligonucleotide, their use in detecting biological molecules, sequencing DNA molecules and generating cDNA molecules for characterizing the differential expression of genes
01/04/2005US6838243 Detecting amplification product in sample; obtain sample, incubate with substrate coupled to probe, detect signal from probe
01/04/2005US6838242 Enhancing the detection of a polynucleotide separated by matched ion polynucleotide chromatography; obtain nucleotide sequences, attach probe, apply polynucleotide mixture to separation gel, elute, detect labeled nucleotide sequences
01/04/2005US6838239 Chitobiase as a reporter enzyme
01/04/2005CA2283509C Novel bicyclonucleoside and oligonucleotide analogue
01/04/2005CA2123133C Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
12/2004
12/30/2004US20040268439 Genes encoding carotenoid compounds
12/30/2004US20040268425 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms
12/30/2004US20040267005 Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof